Product custom-nanocomposites-lipid-nanoparticle-composite-materials

Home > products > custom-nanocomposites> lipid-nanoparticle-composite-materials

Catalog	name	Description	price
R-M1-cs8797	ROS responsive liposomes loaded with CE6+ML385+L-arginine	By combining these three components (CE6, ML385, and L-arginine) within ROS responsive liposomes, it is possible to create a targeted drug delivery system that responds to specific oxidative conditions found in the body. The release of the cargo can be triggered by ROS, leading to local therapeutic effects.	price>
R-M1-cs8798	ROS responsive liposomes loaded with CE6+ML385	The combination of CE6 and ML385 in ROS responsive liposomes can be particularly useful in targeting and treating diseases or conditions characterized by high ROS levels, such as certain cancers, inflammatory disorders, and oxidative stress-related diseases.	price>
R-M2-9508	PLGA-imatinib nanoparticles	PLGA-imatinib nanoparticles can be used as a formulation for treating CML and GISTs, improving drug efficacy and reducing side effects associated with systemic administration.They can potentially be used to co-deliver other chemotherapeutics or radiosensitizers, allowing for synergistic effects in cancer treatment.	price>
R-M1-8676	Blank Lipid nanoparticles-GIn(100nm)	Blank lipome nanoparticles-GIn/Blank liposome nanoparticles-GIn(100nm) can be used for drug loading, drug delivery and targeted cell research.	price>
R-M1-8677	Blank Lipid nanoparticles-CY7/ GIn(100nm)	Blank Lipid nanoparticles-CY7/ GIn(100nm)/Blank liposome nanoparticles-CY7/ GIn(100nm) can be used for drug loading, drug delivery and targeted cell research.	price>
R-M1-8692	Liposome-encapsulated Prussian Blue Nanoparticles	Liposome-encapsulated Prussian Blue nanoparticles offer several advantages. Firstly, liposome encapsulation enhances the stability and biodegradability of Prussian Blue nanoparticles, extending their circulation time within the body. Secondly, liposomes increase the drug loading capacity of nanoparticles, improving their efficiency as drug carriers. Additionally, liposomes possess good targeting abilities, allowing for targeted delivery to specific cells or tissues through modifications in liposome structure or surface modifications.	price>
R-C-6575	HSPC/Chol/DSPE-mPEG2000/DSPE-mPEG2000-maleimide/MPL (49/45/4/1/1, mol/mol) Liposomes	Immunogenic PEGylated liposomes containing free maleimide functional group for maleimide-thiol conjugation,plus TLR4 agonist MPL for adjuvant activity.The liposomes are co-formulated with 1 mol% DSPE-mPEG2000-maleimide,and supplied in a pH-optimized buffer for direct conjugation of the thiol-containing molecule of choice.	price>
R-C-6576	HSPC/Chol/DSPE-mPEG2000/MPL (56.2/38.5/4.3/1, mol/mol) Liposomes	The product is a kind of neutral PEGylated liposome.Neutral liposomes are generally non-toxic and relatively stable in serum.PEG has been proven to improve the stability of liposomes and increase the circulation time of liposomes in the blood.Therefore,PEGylated liposomes have enhanced tumor permeability and retention effect (EPR) and improved tumor uptake.	price>
R-C-6577	HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3, mol/mol) Liposomes	HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3,mol/mol) liposomes,30 mM,extruded and supplied sterile-filtered in glass vial.PEGylated to improve stability,prolong circulation time and reduce reticuloendothelial system clearance.	price>
R-C-6578	DMPC/Chol/DSPE-mPEG2000 (50/45/5, mol/mol) Liposomes	Liposomes composed of a mixture of DMPC(1,2-dimyristoyl-sn-glycero-3-phosphocholine),cholesterol (Chol),and DSPE-mPEG2000(1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]) with mole ratios of 50/45/5 respectively are a type of nanocarrier used in drug delivery and other biomedical applications.	price>

...